Hypoxia and the extracellular matrix: drivers of tumour metastasis
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fi broblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recently published literature discusses the role of the size of a tumor (and the associated hypoxia levels) on its aggressiveness [81,82,83,84,85] and on the efficacy of drug delivery to it [84,86,87].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
“In addition, the accumulation of numerous matrix proteins in the ECM also results in a chronic hypoxia state in the TME[[283]].”
BackgroundHypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A., & Higgins, G. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3070 · Cited by 1,135
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Role of Extracellular Matrix in Development and Cancer Progression
Walker, C., Mojares, E., & Del Río Hernández, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,084
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
“225 – 227 The hypoxic response is mainly mediated by hypoxia-inducible factors (HIFs) that are widely upregulated in human cancers and play a critical role in enabling cancer cells to adapt to hypoxic environments.”
BackgroundNia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Intra-tumor heterogeneity from a cancer stem cell perspective
Prasetyanti, P. R., & Medema, J. P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0600-4 · Cited by 800
Extracellular matrix (ECM) stiffness and degradation as cancer drivers
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27681 · Cited by 715
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Chemodynamic Therapy via Fenton and Fenton‐Like Nanomaterials: Strategies and Recent Advances
Jia, C., Guo, Y., & Wu, F. (2022) · Small · doi:10.1002/smll.202103868 · Cited by 685
Hypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 580
Self-citationExtracellular vesicles in immunomodulation and tumor progression
Marar, C., Starich, B., & Wirtz, D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00899-0 · Cited by 584
Self-citationImpact of the physical microenvironment on tumor progression and metastasis
Spill, F., Reynolds, D. S., Kamm, R. D., & Zaman, M. H. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.007 · Cited by 581
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Semenza, G. L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.036 · Cited by 535
Self-citationGoveia, J., Rohlenova, K., Taverna, F., Treps, L., Conradi, L.-C., Pircher, A., Geldhof, V., de Rooij, L. P. M. H., Kalucka, J., Sokol, L., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.001 · Cited by 468
“Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) isoenzymes (known as lysyl hydroxylases) intracellularly hydroxylate lysine residues in collagen, while lysyl oxidase (LOX), or its homologue LOXL2, extracellularly catalyze the first step in collagen crosslink formation (Gilkes et al., 2014).”
BackgroundTumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 460
Sung, Y.-C., Jin, P.-R., Chu, L.-A., Hsu, F.-F., Wang, M.-R., Chang, C.-C., Chiou, S.-J., Qiu, J. T., Gao, D.-Y., Lin, C.-C., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0570-3 · Cited by 452
Liang, C., Xu, L., Song, G., & Liu, Z. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00458j · Cited by 435
Lüönd, F., Tiede, S., & Christofori, G. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01328-7 · Cited by 427
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 430
Goding, C. R., & Arnheiter, H. (2019) · Genes & Development · doi:10.1101/gad.324657.119 · Cited by 430
“BHLHB 2 /DEC1/BHLHE40 is a bHLH transcription factor that represses MITF under hypoxic conditions (Cheli et al. 2011; Feige et al. 2011) found frequently within growing tumors as a consequence of the chaotic tumor-associated vasculature (Gilkes et al. 2014).”
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fibroblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
BackgroundGunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
“Hypoxia is an important feature of several solid tumors and can cause induction of angiogenesis (Gilkes et al., 2014).”
BackgroundTumor macrophages are pivotal constructors of tumor collagenous matrix
Afik, R., Zigmond, E., Vugman, M., Klepfish, M., Shimshoni, E., Pasmanik-Chor, M., Shenoy, A., Bassat, E., Halpern, Z., Geiger, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151193 · Cited by 375
Poltavets, V., Kochetkova, M., Pitson, S. M., & Samuel, M. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00431 · Cited by 377
The Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
Marcucci, F., Stassi, G., & De Maria, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.13 · Cited by 342
Mechanoresponsive metabolism in cancer cell migration and metastasis
Zanotelli, M. R., Zhang, J., & Reinhart-King, C. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.002 · Cited by 338
Fluegen, G., Avivar-Valderas, A., Wang, Y., Padgen, M. R., Williams, J. K., Nobre, A. R., Calvo, V., Cheung, J. F., Bravo-Cordero, J. J., Entenberg, D., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3465 · Cited by 336
The post-translational modification, SUMOylation, and cancer (Review)
Han, Z.-J., Feng, Y.-H., Gu, B.-H., Li, Y.-M., & Chen, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4280 · Cited by 334
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Fendt, S.-M., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 313
Breast cancer cells rely on environmental pyruvate to shape the metastatic niche
Elia, I., Rossi, M., Stegen, S., Broekaert, D., Doglioni, G., van Gorsel, M., Boon, R., Escalona-Noguero, C., Torrekens, S., Verfaillie, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0977-x · Cited by 309
Phillip, J. M., Aifuwa, I., Walston, J., & Wirtz, D. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071114-040829 · Cited by 301
Self-citationWu, Y., Tang, D., Liu, N., Xiong, W., Huang, H., Li, Y., Ma, Z., Zhao, H., Chen, P., Qi, X., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.009 · Cited by 284
Singh, R. K., Kumar, S., Prasad, D. N., & Bhardwaj, T. R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.001 · Cited by 282
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Galli, F., Aguilera, J. V., Palermo, B., Markovic, S. N., Nisticò, P., & Signore, A. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01586-y · Cited by 278
“regulate the expression of enzymes related to biosynthesis fibres in collagen degradation [77].”
BackgroundInfluencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 274
Wu, Q., Zhou, W., Yin, S., Zhou, Y., Chen, T., Qian, J., Su, R., Hong, L., Lu, H., Zhang, F., et al. (2019) · Hepatology · doi:10.1002/hep.30593 · Cited by 269
“199 inducible factor 1α (HIF-1α), which regulates the transcription of a variety of oncogenes on oxygen deficiency.(3,4) Therefore, in addition to tumor cells, tumor-infiltrating leukocytes (TILs), and tumorassociated macrophages (TAMs), for instance, are susceptible to oxygen shortage and tumor metabolites, eventuall…”
BackgroundEmerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
Nam, G., Choi, Y., Kim, G. B., Kim, S., Kim, S. A., & Kim, I. (2020) · Advanced Materials · doi:10.1002/adma.202002440 · Cited by 267
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
Bioprinting the Cancer Microenvironment
Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00246 · Cited by 248
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 244
Wang, H., Han, X., Dong, Z., Xu, J., Wang, J., & Liu, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902440 · Cited by 244
Cancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced Chemoresistance
Tian, H., Luo, Z., Liu, L., Zheng, M., Chen, Z., Ma, A., Liang, R., Han, Z., Lu, C., & Cai, L. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703197 · Cited by 243
Circulating tumor cell isolation, culture, and downstream molecular analysis
Sharma, S., Zhuang, R., Long, M., Pavlovic, M., Kang, Y., Ilyas, A., & Asghar, W. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.007 · Cited by 240
Lin, Z., Song, J., Gao, Y., Huang, S., Dou, R., Zhong, P., Huang, G., Han, L., Zheng, J., Zhang, X., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102312 · Cited by 237
“Hypoxia is a key feature of the tumor microenvironment, and tumor cells must activate the HIF-signaling pathway for adaption to hypoxia [31,32].”
BackgroundFibronectin in Cancer: Friend or Foe
Lin, T.-C., Yang, C.-H., Cheng, L.-H., Chang, W.-T., Lin, Y.-R., & Cheng, H.-C. (2019) · Cells · doi:10.3390/cells9010027 · Cited by 234
“Due to the entities of genomic instability and heterogeneity in tumor cells, some tumor cells, however, adapt to hypoxia, survive, and become highly metastatic [199,202]”
BackgroundFraley, S. I., Wu, P.-H., He, L., Feng, Y., Krisnamurthy, R., Longmore, G. D., & Wirtz, D. (2015) · Scientific Reports · doi:10.1038/srep14580 · Cited by 234
Self-citationAdvanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications
Wang, Z., Jin, A., Yang, Z., & Huang, W. (2023) · ACS Nano · doi:10.1021/acsnano.3c02303 · Cited by 229
Wei, S. C., & Yang, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.09.009 · Cited by 225
Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells
Donato, C., Kunz, L., Castro-Giner, F., Paasinen-Sohns, A., Strittmatter, K., Szczerba, B. M., Scherrer, R., Di Maggio, N., Heusermann, W., Biehlmaier, O., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108105 · Cited by 224
“…Obenauf, 2016; Minn et al., 2005) or genes involved in the formation of a pre-metastatic niche (Esposito et al., 2018; Peinado et al., 2017), interaction with the immune system (Coffelt et al., 2015; Szczerba et al., 2019), or microenvironmental signals (Gilkes et al., 2014; Quail and Joyce, 2013).”
Cancer Genome Evolutionary Trajectories in Metastasis
Birkbak, N. J., & McGranahan, N. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.004 · Cited by 223
“…et al., 2017), the mechanistic basis of metastatic dissemination(Chaffer and Weinberg, 2011), hypoxia and the extracellular matrix (Barkan et al., 2010; Gilkes et al., 2014), and the role of epithelial-mesenchymal transition(David et al., 2016; Esposito et al., 2019; Kalluri and Weinberg, 2009)”
BackgroundOxygen Sensing and Homeostasis
Prabhakar, N. R., & Semenza, G. L. (2015) · Physiology · doi:10.1152/physiol.00022.2015 · Cited by 220
Self-citationZhuang, J., Wang, B., Chen, H., Zhang, K., Li, N., Zhao, N., & Tang, B. Z. (2023) · ACS Nano · doi:10.1021/acsnano.2c12319 · Cited by 217
Tumor hypoxia: From basic knowledge to therapeutic implications
Liao, C., Liu, X., Zhang, C., & Zhang, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.011 · Cited by 223
Li, X., & Wang, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.44943 · Cited by 211
“ECM stiffness may cause intracellular contractions and a subsequent increase in the stiffness of an actin cytoskeleton that favors cancer migration [32].”
BackgroundPeng, D. H., Ungewiss, C., Tong, P., Byers, L. A., Wang, J., Canales, J. R., Villalobos, P. A., Uraoka, N., Mino, B., Behrens, C., et al. (2017) · Oncogene · doi:10.1038/onc.2016.358 · Cited by 211
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Chae, Y. C., Vaira, V., Caino, M. C., Tang, H.-Y., Seo, J. H., Kossenkov, A. V., Ottobrini, L., Martelli, C., Lucignani, G., Bertolini, I., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.004 · Cited by 209
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Zhao, Y., Xing, C., Deng, Y., Ye, C., & Peng, H. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.039 · Cited by 202
“At present, it is widely recognized that the microenvironment in which solid tumors commonly grow is hypoxia.(10) Indeed, malignant tumors are a serious threat to human health and the hypoxic microenvironment (HME) is tightly correlated with the malignant progression of tumors (e.”
BackgroundHu, X.-X., He, P.-P., Qi, G.-B., Gao, Y.-J., Lin, Y.-X., Yang, C., Yang, P.-P., Hao, H., Wang, L., & Wang, H. (2017) · ACS Nano · doi:10.1021/acsnano.7b00781 · Cited by 205
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
He, G., Peng, X., Wei, S., Yang, S., Li, X., Huang, M., Tang, S., Jin, H., Liu, J., Zhang, S., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01440-5 · Cited by 201
“In addition, integrins facilitate CD44 [161], ICAM [160], ECM [163] and tetraspanin [160] participation in the interactions between exosomes and target cells, and all these interactions are tightly associated with hypoxia (see the details in the following references: ICAM-1[167, 168], ECM [169], CD44 [170, 171], and t…”
BackgroundInfluentialThe challenge of targeting cancer stem cells to halt metastasis
Agliano, A., Calvo, A., & Box, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.003 · Cited by 200
Goetzman, E. S., & Prochownik, E. V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00129 · Cited by 199
Yang, H., Zhang, H., Yang, Y., Wang, X., Deng, T., Liu, R., Ning, T., Bai, M., Li, H., Zhu, K., et al. (2020) · Theranostics · doi:10.7150/thno.44419 · Cited by 196
“In the case of insufficient oxygen supply, a vast majority of the adaptive reprogramming in cancer cells are driven by HIF-1 protein [11, 24].”
BackgroundReview of optical breast imaging and spectroscopy
Grosenick, D., Rinneberg, H., Cubeddu, R., & Taroni, P. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.9.091311 · Cited by 187
Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them
Yahaya, M. A. F., Lila, M. A. M., Ismail, S., Zainol, M., & Afizan, N. A. R. N. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/2368249 · Cited by 187
“In addition, the hypoxic condition promotes healthy cells to behave abnormally due to the remodelling of its extracellular matrix which eventually increases the metastatic and migratory progressions [65, 66].”
BackgroundLiu, L., He, H., Luo, Z., Zhou, H., Liang, R., Pan, H., Ma, Y., & Cai, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910176 · Cited by 186
FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism
Zhang, C., Liao, Y., Liu, P., Du, Q., Liang, Y., Ooi, S., Qin, S., He, S., Yao, S., & Wang, W. (2020) · Theranostics · doi:10.7150/thno.44868 · Cited by 186
“Hypoxia is a common feature in solid tumours and has been linked to cancer aggressiveness [57-60].”
BackgroundBioengineered nanogels for cancer immunotherapy
Ma, X., Li, S.-J., Liu, Y., Zhang, T., Xue, P., Kang, Y., Sun, Z.-J., & Xu, Z. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00247g · Cited by 185
Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality
McIntyre, A., & Harris, A. L. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404271 · Cited by 185
Interaction of MSC with tumor cells
Melzer, C., Yang, Y., & Hass, R. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0143-0 · Cited by 185
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer
Xiang, Y., Ye, Y., Lou, Y., Yang, Y., Cai, C., Zhang, Z., Mills, T., Chen, N.-Y., Kim, Y., Muge Ozguc, F., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx223 · Cited by 180
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
Choi, S. Y. C., Lin, D., Gout, P. W., Collins, C. C., Xu, Y., & Wang, Y. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.009 · Cited by 177
Jayatilaka, H., Tyle, P., Chen, J. J., Kwak, M., Ju, J., Kim, H. J., Lee, J. S. H., Wu, P.-H., Gilkes, D. M., Fan, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms15584 · Cited by 177
Self-citationMultiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment
Norton, K.-A., Gong, C., Jamalian, S., & Popel, A. S. (2019) · Processes · doi:10.3390/pr7010037 · Cited by 175
Zhang, R. X., Ahmed, T., Li, L. Y., Li, J., Abbasi, A. Z., & Wu, X. Y. (2017) · Nanoscale · doi:10.1039/c6nr08486a · Cited by 174
Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
Liang, J., Li, H., Han, J., Jiang, J., Wang, J., Li, Y., Feng, Z., Zhao, R., Sun, Z., Lv, B., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02858-3 · Cited by 169
Wang, S., Wu, Q., Chen, T., Su, R., Pan, C., Qian, J., Huang, H., Yin, S., Xie, H., Zhou, L., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.011 · Cited by 168
Paving the Rho in cancer metastasis: Rho GTPases and beyond
Jansen, S., Gosens, R., Wieland, T., & Schmidt, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.002 · Cited by 167
Miyamoto, K., Seki, N., Matsushita, R., Yonemori, M., Yoshino, H., Nakagawa, M., & Enokida, H. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.179 · Cited by 167
The cancer matrisome: From comprehensive characterization to biomarker discovery
Socovich, A. M., & Naba, A. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.06.005 · Cited by 161
Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer
Xue, M., Chen, W., & Li, X. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2042-y · Cited by 160
Chen, M., Liang, X., Gao, C., Zhao, R., Zhang, N., Wang, S., Chen, W., Zhao, B., Wang, J., & Dai, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b03674 · Cited by 160
Liu, Y., Teng, L., Chen, L., Ma, H., Liu, H., & Zhang, X. (2018) · Chemical Science · doi:10.1039/c8sc01684d · Cited by 157
Yang, L., & Lin, P. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.001 · Cited by 155
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Li, Y., Jin, H., Li, Q., Shi, L., Mao, Y., & Zhao, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02041-8 · Cited by 184
“Excessive hypoxia within tissues disrupts microenvironmental homeostasis, fostering the emergence of a hypoxic, hypoglycemic, and acidic TME conducive to tumor initiation and growth [145, 146].”
BackgroundKo, C., Huang, C.-C., Lin, H.-Y., Juan, C.-P., Lan, S., Shyu, H., Wu, S., Hsiao, P., Huang, H., Shun, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3297 · Cited by 159
Zhan, H., Zhou, B., Cheng, Y., Xu, J., Wang, L., Zhang, G., & Hu, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.041 · Cited by 171
Zhou, L., Jiang, J., Huang, Z., Jin, P., Peng, L., Luo, M., Zhang, Z., Chen, Y., Xie, N., Gao, W., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01638-1 · Cited by 167
Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Melzer, C., von der Ohe, J., Lehnert, H., Ungefroren, H., & Hass, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0595-x · Cited by 148
Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective
Sufyan, M., Shokat, Z., & Ashfaq, U. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107356 · Cited by 197
The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
Zhong, X., Chen, B., & Yang, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000486816 · Cited by 148
Li, Y.-R., Fang, Y., Lyu, Z., Zhu, Y., & Yang, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04575-9 · Cited by 180
“Upon stimulation, CSC proliferation is indirectly augmented via the extracellular signal-regulated kinase (ERK) pathway [98].”
Background
Metadata
- Authors
- Gilkes, D. M., Semenza, G. L., & Wirtz, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wirtz, Denis
- Venue
- Nature Reviews Cancer
- Published
- 2014-05-15
- Volume
- 14
- Issue
- 6
- Pages
- 430-439
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4283800
- OpenAlex
- W2069518226
- Cited by
- 1,520
- References
- 209
- Citations by year
- 2026: 99 · 2025: 129 · 2024: 149 · 2023: 151 · 2022: 175 · 2021: 192 · 2020: 164 · 2019: 132 · 2018: 106 · 2017: 95 · 2016: 75 · 2015: 41 · 2014: 9
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA143868, R01CA174388, K99CA181352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tumor hypoxia, extracellular matrix, tumour metastasis, tumor microenvironment, stromal cells, tumor cell motility, tumor cell proliferation
- MeSH terms
- Hypoxia, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.